Key facts
- Xealth’s last known valuation is $83.4M (Feb 2024).
- It has raised $57.1M across 5 recorded rounds; the latest was Seed Round ($3.4M) in Feb 2024.
- Xealth has filed 5 Form Ds with the SEC since 2017, most recently Feb 2024 ($3.4M sold to 19 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 5 rounds
- ·Watchlist + deal alerts for Xealth
Funding rounds
5 roundsAbout Xealth
Operator of digital health programs intended to scale healthcare system workflows. The company offers a clinical artificial intelligence engine to the care teams to manually or automatically order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient's email or patient portal and then monitor activity on an individual or system-wide basis, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2016
- Employees
- 61
- Website
- xealth.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Xealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xealth in its N-PORT filings yet. We sweep new filings monthly.